Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily T member 6 (OR2T6) is a member of the large family of olfactory receptors, which are G protein-coupled receptors (GPCRs) expressed in the olfactory epithelium in the nose. These receptors detect odorant molecules and initiate a neuronal response leading to the perception of smell. OR2T6 contains seven transmembrane domains characteristic of GPCRs and participates in the G protein-mediated transduction of olfactory signals. It is encoded by a single-exon gene, and while it displays typical molecular motifs of olfactory GPCRs, there is no evidence it functions as a therapeutic target or has direct links to human disease, and it may be classified as a pseudogene in some nomenclatures[2][4][5][7]. OR2T6 is not considered a therapeutic target, but rather a sensory receptor, and in some annotations may be a pseudogene[4][6]. No known drugs, established disease roles, nor clinical biomarkers or safety concerns are associated with this receptor[2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily T member 6 (OR2T6).